NS Wind Down Co Inc (NSTGQ)
0.093
-0.01
(-7.00%)
USD |
OTCM |
Jun 03, 16:00
NS Wind Down Enterprise Value: 135.14M for June 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 03, 2024 | 135.14M |
May 31, 2024 | 135.47M |
May 30, 2024 | 135.89M |
May 29, 2024 | 136.43M |
May 28, 2024 | 135.10M |
May 24, 2024 | 135.47M |
May 23, 2024 | 135.09M |
May 22, 2024 | 136.88M |
May 21, 2024 | 136.51M |
May 20, 2024 | 136.95M |
May 17, 2024 | 136.44M |
May 16, 2024 | 137.64M |
May 15, 2024 | 136.68M |
May 14, 2024 | 136.67M |
May 13, 2024 | 135.72M |
May 10, 2024 | 135.43M |
May 09, 2024 | 135.84M |
May 08, 2024 | 136.27M |
May 07, 2024 | 138.57M |
May 06, 2024 | 139.81M |
May 03, 2024 | 140.53M |
May 02, 2024 | 139.18M |
May 01, 2024 | 139.81M |
April 30, 2024 | 143.03M |
April 29, 2024 | 143.65M |
Date | Value |
---|---|
April 26, 2024 | 144.62M |
April 25, 2024 | 144.38M |
April 24, 2024 | 145.10M |
April 23, 2024 | 145.10M |
April 22, 2024 | 146.78M |
April 19, 2024 | 140.29M |
April 18, 2024 | 138.97M |
April 17, 2024 | 134.37M |
April 16, 2024 | 134.42M |
April 15, 2024 | 134.62M |
April 12, 2024 | 134.27M |
April 11, 2024 | 134.70M |
April 10, 2024 | 134.64M |
April 09, 2024 | 135.19M |
April 08, 2024 | 134.83M |
April 05, 2024 | 134.87M |
April 04, 2024 | 135.23M |
April 03, 2024 | 134.90M |
April 02, 2024 | 135.47M |
April 01, 2024 | 135.23M |
March 28, 2024 | 134.51M |
March 27, 2024 | 134.03M |
March 26, 2024 | 133.50M |
March 25, 2024 | 134.51M |
March 22, 2024 | 134.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
132.73M
Minimum
Feb 21 2024
3.458B
Maximum
Apr 28 2021
1.106B
Average
848.48M
Median
Enterprise Value Benchmarks
Bruker Corp | 10.45B |
Azenta Inc | 1.926B |
Harvard Bioscience Inc | 169.46M |
Bionano Genomics Inc | 40.58M |
Akoya Biosciences Inc | 114.89M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -37.41M |
Revenue (Quarterly) | 48.09M |
Total Expenses (Quarterly) | 84.56M |
EPS Diluted (Quarterly) | -0.78 |
Gross Profit Margin (Quarterly) | 36.19% |
Profit Margin (Quarterly) | -77.80% |
Earnings Yield | -3.80K% |
Normalized Earnings Yield | -3795.70 |